Value of plasma the soluble CD14 subtype in early diagnosis of sepsis patients with acute renal injury

SHEN Wenwen; LIU Qin; HUANG Kai; JIANG Xiaogan; CHEN Shanghua

doi:10.7619/jcmp.20232835

Journal of Clinical Medicine in Practice > 2024 > 28(10): 46-50. > DOI: 10.7619/jcmp.20232835

SHEN Wenwen, LIU Qin, HUANG Kai, JIANG Xiaogan, CHEN Shanghua. Value of plasma the soluble CD14 subtype in early diagnosis of sepsis patients with acute renal injury[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 46-50. DOI: 10.7619/jcmp.20232835

Citation:

PDF (1074 KB)

Value of plasma the soluble CD14 subtype in early diagnosis of sepsis patients with acute renal injury

1.
Department of Critical Care Medicine, Wuhu Hospital Affiliated to East China Normal University, Wuhu, Anhui, 241000
2.
Department of Critical Care Medicine, Yijishan Hospital Affiliated to Wannan Medical College, Wuhu, Anhui, 241000

More Information

Received Date: September 05, 2023
Revised Date: December 03, 2023
Available Online: May 31, 2024

Graphical Abstract

Abstract

Abstract

Objective
To evaluate the diagnostic value of plasma the soluble CD14 subtype (sCD14-ST, renamed as presepsin) in early diagnosis of sepsis patients with acute kidney injury (AKI).
Methods
A total of 110 patients with AKI in intensive care unit(ICU)of Wuhu Hospital Affiliated to East China Normal University from January 2021 to December 2022 were prospectively selected. The patients were divided into AKI stage 1 group (n=34), AKI stage 2 group (n=36) and AKI stage 3 group (n=40) according to the staging criteria defined byKidney Disease: Improving Global Outcomes (KDIGO) in 2012, and 53 non-AKI patients in the same period were selected as the control group. The patients were further divided into non-sepsis group and sepsis group according to whether combined sepsis or not. Plasma Presepsin levels were recorded in all the patients. Receiver operating characteristic (ROC) curve was drawn to evaluate the diagnostic value of Presepsin inearly sepsis in AKI patients, and the optimal cutoff value was found using Jorden index.
Results
The level of Presepsin in the sepsis group was higher than that in non-sepsis group (P < 0.05). In non-sepsis patients, the level of Presepsin increased gradually with the aggravation of renal function injury (P < 0.05). The level of Presepsin in stage 3 AKI group was higher than that in non-AKI group (P < 0.01). ROC curve analysis results showed that thearea under the curve (AUC) of Presepsin level for diagnosing sepsis in stage 1 AKI group, stage 2 AKI group and stage 3 AKI group was smaller than that in non-AKI group (P > 0.05).
Conclusion
Presepsin can be used as a marker for early diagnosis of sepsis in AKI patients, but different thresholds should be used according to the severity of renal impairment.
- Presepsin,
- sepsis,
- acute kidney injury,
- early diagnosis

FullText(HTML)

References (17)

References

[1]	SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. doi: 10.1001/jama.2016.0287
[2]	TAMBO M, TAGUCHI S, NAKAMURA Y, et al. Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis[J]. BMC Urol, 2020, 20(1): 23. doi: 10.1186/s12894-020-00596-4
[3]	KELLUM J A, LAMEIRE N, ASPELIN P, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury[J]. Kidney Int Suppl, 2012, 2(1): 1-138. doi: 10.1038/kisup.2012.1
[4]	RHODES A, EVANS L E, ALHAZZANI W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016[J]. Intensive Care Med, 2017, 43(3): 304-377. doi: 10.1007/s00134-017-4683-6
[5]	潘玉静, 张路霞. 估算肾小球滤过率的评价方法[J]. 中华内科杂志, 2016, 55(3): 237-240.
[6]	MANRIQUE-CABALLERO C L, DEL RIO-PERTUZ G, GOMEZ H. Sepsis-Associated Acute Kidney Injury[J]. Crit Care Clin, 2021, 37(2): 279-301. doi: 10.1016/j.ccc.2020.11.010
[7]	LABRO G, APTEL F, PUYRAVEAU M, et al. Impact on antimicrobial consumption of procalcitonin-guided antibiotic therapy for pneumonia/pneumonitis associated with aspiration in comatose mechanically ventilated patients: a multicenter, randomized controlled study[J]. Ann Intensive Care, 2021, 11(1): 145. doi: 10.1186/s13613-021-00931-4
[8]	DZIARSKI R, TAPPING R I, TOBIAS P S. Binding of bacteri al peptidoglycan to CD14[J]. J Biol Chem, 1998, 273(15): 8680-8690. doi: 10.1074/jbc.273.15.8680
[9]	SHIRAKAWA K, NAITOU K, HIROSE J, et al. The new sepsis marker, sCD14-ST, induction mechanism in the rabbit sepsis models[J]. Crit Care, 2010, 14(Suppl 2): 19. doi: 10.1186/cc9122
[10]	HASSAN E A, ABDEL REHIM A S, AHMED A O, et al. Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ⅲ Patients[J]. Medicina (Kaunas, Lithuania), 2019, 55(2): 1-11.
[11]	KOIZUMI Y, SAKANASHI D, MOHRI T, et al. Can Presepsin uniformly respond to various pathogens- an in vitro assay of new sepsis marker[J]. BMC Immunol, 2020, 21(1): 33. doi: 10.1186/s12865-020-00362-z
[12]	NAKAMURA Y, ISHIKURA H, NISHIDA T, et al. Usefulness of Presepsin in the diagnosis of sepsis in patients with or without acute kidney injury[J]. BMC Anesthesiol, 2014, 14: 88. doi: 10.1186/1471-2253-14-88
[13]	HAN S, KIM M J, KO H J, et al. Diagnostic and Prognostic Roles of C-Reactive Protein, Procalcitonin, and Presepsin in Acute Kidney Injury Patients Initiating Continuous Renal Replacement Therapy[J]. Diagnostics (Basel), 2023, 13(4): 777. doi: 10.3390/diagnostics13040777
[14]	奚希相, 李文放, 马金苗, 等. 尿NGAL联合MEDS评分评估脓毒症合并急性肾损伤患者病情及预后[J]. 第二军医大学学报, 2017, 38(2): 244-248. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201702020.htm
[15]	TAKAHASHI G, SHIBATA S, FUKUI, et al. Diagnostic accuracy of procalcitonin and presepsin for infectious disease in patients with acute kidney injury[J]. Diagn Microbiol Infect Dis, 2016, 86(2): 205-210. doi: 10.1016/j.diagmicrobio.2016.07.015
[16]	NAKAMURA Y, MURAI A, MIZUNUMA M, et al. Potential use of procalcitonin as biomarker for bacterial sepsis in patients with or without acute kidney injury[J]. J Infect Chemother, 2015, 21(4): 257-263. doi: 10.1016/j.jiac.2014.12.001
[17]	NAKAMURA Y, HOSHINO K, KIYOMI F, et al. Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury[J]. Clin Chim Acta, 2019, 490: 200-206. doi: 10.1016/j.cca.2018.09.013

[1]	WANG Tianwei, TANG Chengbin, JIANG Wei, YU Hailong, SHAO Jun, YUAN Jing. Research progress on early biomarkers of cardiac surgery-associated acute kidney injury[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 131-139, 143. DOI: 10.7619/jcmp.20232815
[2]	SUN Weiwei, HUANG Xiaoying, WANG Yadong. Value of HELENICC score in predicting early mortalityof septic-related acute kidney injury patients with continuous renal replacement therapy[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 29-34. DOI: 10.7619/jcmp.20231689
[3]	ZHOU Min, ZHU Feng, WANG Xiaoyan, HE Xiaofang. Retrospective analysis in characteristics of missed diagnosed and misdiagnosed cases by breast ultrasound examination in early diagnosis of breast cancer and their influencing factors[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 35-38. DOI: 10.7619/jcmp.20213648
[4]	WANG Yan, ZOU Huiling, GANG Qiang, SUN Yu. Value of miRNA-93 in early diagnosis of patients with type 2 diabetes mellitus complicated with acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(18): 111-115. DOI: 10.7619/jcmp.20212960
[5]	YIN Jianhua, ZHU Jianwei, GU Lichao, ZHONG Yafei, YANG Yao, JIANG Nan, YANG Lijun. Clinical value of early diagnosis in elderly patients with pulmonary embolism[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 103-106. DOI: 10.7619/jcmp.201917029
[6]	LIU Hong, LIU Peizheng. Value of serum procalcitonin in the early diagnosis of children with severe pneumonia[J]. Journal of Clinical Medicine in Practice, 2016, (7): 105-108. DOI: 10.7619/jcmp.201607031
[7]	ZHU Hongchao, MA Di, WANG Fei, ZHANG Ruixue, LU Xiaoye, ZHU Changqing. Comparison between immune enhancement turbidimetry and immumofluorescence methodin detections of neutrophil gelatinase-associated lipocalin in plasma and urine and their values in diagnosis of sepsis-induced acute kidney injury[J]. Journal of Clinical Medicine in Practice, 2016, (3): 32-35. DOI: 10.7619/jcmp.201603010
[8]	JIAN Wen, ZHAO Ying. Study on the effect of knowledge of prevention and treatment of gastric cancer in early diagnosis of gastric cancer[J]. Journal of Clinical Medicine in Practice, 2015, (22): 31-33. DOI: 10.7619/jcmp.201522011
[9]	LI Jiajin, GUO Cuiyan, NA Jun, FU Qiang, LIU Li, MENG Qingkun. Value of cystatin C in early diagnosis of nephropathy induced by contrast agent[J]. Journal of Clinical Medicine in Practice, 2015, (1): 20-22. DOI: 10.7619/jcmp.201501006
[10]	SHE Xiaoyin, ZHANG Haibo, MU Juxiang. Early application of continuous renal replacement therapy in acute kidney injury after cardiac surgery[J]. Journal of Clinical Medicine in Practice, 2013, (21): 94-96. DOI: 10.7619/jcmp.201321026

Cited By

Cited by

Periodical cited type(10)

1.	方敏华. 三球式呼吸训练器训练应用于无创正压通气治疗慢性阻塞性肺疾病患者的效果分析. 基层医学论坛. 2024(11): 35-37 .
2.	许明璐，杨萧含，刘倩楠，尹畅. 老年人慢性病共病关联规则分析. 实用临床医药杂志. 2024(13): 103-108 . 本站查看
3.	尹宁宁，王志娟，张海霞. 慢性阻塞性肺疾病患者并发心血管疾病危险因素及预测模型建立. 川北医学院学报. 2023(05): 608-612 .
4.	陈婷，陈丹凤，翁克姬. 负荷拓展呼吸训练联合血糖控制对慢阻肺合并高血压患者肺功能及血压控制效果的影响. 心血管病防治知识. 2023(18): 83-85 .
5.	黎玲，林丽芳. 自我管理对慢性阻塞性肺疾病合并高血压患者肺功能及生活质量的影响研究. 心血管病防治知识. 2023(22): 73-75 .
6.	曾丹虹. 多学科协作干预对AECOPD合并高血压患者肺功能的影响. 心血管病防治知识. 2023(25): 42-44 .
7.	陈春红. 自我管理对慢性阻塞性肺疾病合并高血压患者肺功能及生活质量的影响. 心血管病防治知识. 2022(06): 65-67 .
8.	陈芳，孙莲. 老年高血压伴慢性阻塞性肺疾病患者临床研究进展. 实用医院临床杂志. 2022(03): 229-231 .
9.	王龙龙，许淑娣，马洪鸽，马静文，王警建，杨淑涵，张明. 慢性阻塞性肺疾病合并抑郁患者的脑皮质边缘环路研究. 实用临床医药杂志. 2022(11): 38-41 . 本站查看
10.	石婷婷，刘双全，高晓华，张锋英. 慢性阻塞性肺疾病合并社区获得性肺炎患者的临床特征及其影响因素分析. 医学信息. 2022(19): 38-42 .

Other cited types(6)

Get Citation

PDF

XML

Article views (146) PDF downloads (3) Cited by(16)

Turn off MathJax

Article Contents

Abstract

References

Value of plasma the soluble CD14 subtype in early diagnosis of sepsis patients with acute renal injury